NCT01954602

Brief Summary

The specific goal of this study is to compare the deep biliary cannulation rate and complication rates associated with use of touch and no touch guide-wire biliary cannulation techniques.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 5, 2013

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 7, 2013

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

March 28, 2017

Status Verified

March 1, 2017

Enrollment Period

1.7 years

First QC Date

August 5, 2013

Last Update Submit

March 24, 2017

Conditions

Keywords

Biliary cannulationEndoscopic retrograde cholangiopancreatographyTouch guide-wire techniquesNo touch guide-wire techniques

Outcome Measures

Primary Outcomes (1)

  • Cannulation success rate

    No more than 5 minutes of biliary cannulation or 5 unintended pancreatic duct cannulation with the guidewire, with both techniques

Secondary Outcomes (1)

  • Incidences of PEP

    from the intervention until two days

Study Arms (2)

Touch group

ACTIVE COMPARATOR

Sphincterotome assisted guide-wire cannulation

Procedure: Sphincterotome assisted guide-wire cannulation

No touch group

EXPERIMENTAL

Guide-wire cannulation

Procedure: Guide-wire cannulation

Interventions

Direct guide-wire hovering a few millimeters through the catheter or sphincterotome

No touch group

Sphincterotome is inserted initially a few millimeters through the papillary orifice

Touch group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older
  • Clinical symptoms, laboratory findings and radiological evidences of biliary disease
  • Willing and able to comply with the study procedures and provide written informed consent to participate in the study

You may not qualify if:

  • Age \<18 yars
  • Patients with previous sphincterotomy
  • Patients with previous papillary endoscopic balloon dilation
  • Presence of a previously placed plastic or metal biliary stent
  • Presence of any esophageal or gastro/duodenal stent
  • Pancreatic or ampullary cancer, proven by imaging and/or cytology and/or histology, are excluded as PEP is very uncommon in these subgroups and tumour-related anatomical variation may alter cannulation technique (consider substratify results for this subgroup, but exclude if duodenal stenosis precludes an attempt on the papilla)
  • Patients with surgically altered anatomy (Bilroth II gastrectomy and Roux en Y anastomosis) are excluded as cannulation technique is fundamentally different from that in normal anatomy
  • Presence of a diverticular papilla
  • Presence of a duodenal stenosis
  • Presence of a pancreas divisum
  • Patients with contraindication to endoscopic procedures
  • Hemodinynamic instability, any acute illness or exacerbation of chronic illness, acute infections.
  • Platelet count less than 50,000/mm3 and INR no greater than 1.5 times upper limit of normal
  • Inability or refusal to give informed consent.
  • Refusal to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Unità Sanitaria Locale

Bologna, Bologna, 40100, Italy

Location

Related Publications (6)

  • Rabenstein T, Schneider HT, Nicklas M, Ruppert T, Katalinic A, Hahn EG, Ell C. Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc. 1999 Nov;50(5):628-36. doi: 10.1016/s0016-5107(99)80010-8.

    PMID: 10536317BACKGROUND
  • Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991 May-Jun;37(3):383-93. doi: 10.1016/s0016-5107(91)70740-2.

    PMID: 2070995BACKGROUND
  • Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology. 1991 Oct;101(4):1068-75.

    PMID: 1889699BACKGROUND
  • Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996 Sep 26;335(13):909-18. doi: 10.1056/NEJM199609263351301.

    PMID: 8782497BACKGROUND
  • Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998 Jul;48(1):1-10. doi: 10.1016/s0016-5107(98)70121-x.

    PMID: 9684657BACKGROUND
  • Bassi M, Luigiano C, Ghersi S, Fabbri C, Gibiino G, Balzani L, Iabichino G, Tringali A, Manta R, Mutignani M, Cennamo V. A multicenter randomized trial comparing the use of touch versus no-touch guidewire technique for deep biliary cannulation: the TNT study. Gastrointest Endosc. 2018 Jan;87(1):196-201. doi: 10.1016/j.gie.2017.05.008. Epub 2017 May 18.

MeSH Terms

Conditions

Biliary Tract Diseases

Condition Hierarchy (Ancestors)

Digestive System Diseases

Study Officials

  • Elio Jovine, MD

    AUSL Bologna

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

August 5, 2013

First Posted

October 7, 2013

Study Start

July 1, 2013

Primary Completion

March 1, 2015

Study Completion

April 1, 2015

Last Updated

March 28, 2017

Record last verified: 2017-03

Locations